Close Menu

layoffs

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific eliminated about 410 positions in the third quarter, the company disclosed in its Form 10-Q recently.

NEW YORK (GenomeWeb News) – Sigma-Aldrich laid off 130 employees during the third quarter as part of a restructuring plan, the St. Louis company disclosed in its Form 10-Q recently.

NEW YORK (GenomeWeb News) – PerkinElmer laid off 66 employees during the third quarter as part of a planned shift in its business, the company disclosed in its Form 10-Q filed with US Securities Exchange on Tuesday.

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has launched a reorganization of the firm that includes the creation of two new business groups and the elimination of approximately 400 to 600 management positions.

NEW YORK (GenomeWeb News) – Mitochondrial DNA-based test developer Mitomics today announced a realignment of its product development operations, resulting in the elimination of eight jobs.

NEW YORK (GenomeWeb News) – Sigma-Aldrich has laid off 30 employees as part of a restructuring plan to "exit various sales office locations in Europe," the company disclosed in a document filed with the US Securities and Exchange Commission recently.

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 229 employees in the second quarter, the company disclosed in a document filed with the US Securities and Exchange Commission on Tuesday.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific disclosed in its quarterly earnings document that it has eliminated about 530 jobs through the first six months of 2012.
It also disclosed an acquisition for a price of potentially up to $7.5 million.

This story was originally posted on June 4.

NEW YORK (GenomeWeb News) – Complete Genomics is laying off 55 employees in order to reduce its cash burn and has hired a financial advisor to explore strategic alternatives, the company said today.

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.